Protagenic Therapeutics, Inc.\new Treasury Stock, Value
Protagenic Therapeutics, Inc.\new (PTIX) had Treasury Stock, Value of $100.00 thousand as of 2015-12-31, per its 10-K/A filed 2017-05-08.
Discontinued › Balance Sheet › Equity › Equity, Including Portion Attributable to Noncontrolling Interest › Equity, Attributable to Parent
us-gaap:TreasuryStockValue · last filed 2017-05-08
- 2015-12-31: Treasury Stock, Value $100.00K.
- 2014-12-31: Treasury Stock, Value $100.00K.
- 2014-06-30: Treasury Stock, Value $0.00.
- 2011-09-30: Treasury Stock, Value $4.98M.
| Period end | Treasury Stock, Value |
|---|---|
| 2015-12-31 | $100.00K 10-K/A · filed 2017-05-08 |
| 2014-12-31 | $100.00K 8-K/A · filed 2016-07-12 |
| 2014-06-30 | $0.00 10-K · filed 2014-10-14 |
| 2011-09-30 | $4.98M 10-Q · filed 2011-11-14 |
| 2011-06-30 | $4.98M 10-Q/A · filed 2011-09-07 |
| 2010-12-31 | $4.98M 10-Q · filed 2011-11-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Decoy Therapeutics Inc. (DCOY) | United States | $0.002B | -0.27 |
| Nexentis Technologies Inc. (NXTS) | $0.002B | ||
| ORAGENICS INC (OGEN) | United States | $0.002B | |
| JUPITER NEUROSCIENCES, INC. (JUNS) | United States | $0.002B | -0.02 |
| BioXcel Therapeutics, Inc. (BTAI) | United States | $0.002B | |
| ZyVersa Therapeutics, Inc. (ZVSA) | United States | $0.002B | |
| CDT Equity Inc. (CDT) | United States | $0.000B | -0.01 |
| Matinas BioPharma Holdings, Inc. (MTNB) | United States | $0.003B | |
| Aditxt, Inc. (ADTX) | United States | $0.000B | |
| Rafael Holdings, Inc. (RFL) | United States | $0.000B | -0.00 |